June 25, 2021
Japanese physicians are growing increasingly comfortable with using biosimilars as their initial quality worries taper off. While ensuring stable supplies remains a challenge, there is no doubt that follow-on biologics demand by frontline clinicians is on the rise. The anti-TNFα...read more